News
StockStory.org on MSN1d
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To KnowWhat Happened? A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous ...
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Omnicell (OMCL – Research Report) today. The company’s shares closed yesterday at ...
StockStory.org on MSN3d
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have ...
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat reports. Four equities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results